Factors associated to glycaemic control in patients with type 2 diabetes

被引:0
|
作者
Panarotto, Daniel [1 ]
Teles, Alisson Roberto [1 ]
Schumacher, Marina Verdi [1 ]
机构
[1] Univ Caxias do Sul, Lab Fisiol, Dept Clin Med, BR-95010550 Caxias Do Sul, RS, Brazil
来源
关键词
diabetes mellitus; prevention; control; primary health care; quality of health car; outcomes;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE. Evaluate the factors influencing blood glucose control of type 2 diabetic patients attended at a tertiary health care center. METHODS. A retrospective study by review of medical records of patients who attended the Diabetes Clinic at the University of Caxias do Sul was carried out. Patients were evaluated for glycaemic and metabolic control and divided according to glycated hemoglobin at the beginning and end of the period in question,in compensated and not compensated The factors associated with glycaemic control were analyzed. RESULTS. Seventy three patients were included in the analysis. On the average, improvement of parameters related to glycaemic pressure and lipid control during the average of 20 months of treatment was observed. In the beginning of the follow-up period, 25% of patients had glycated hemoglobin < 7%, 22.7% had LDL cholesterol < 100mg/dL, 8.7% had systolic blood pressure < 130 mmHg and diastolic < 80 mmHg and no patients had all parameters meeting the recommended goals. At the last visit the percentages were, 42.3%, 37.5%, 30.2% and 9.6% respectively. In the multivariate analysis, youngerage, higher levels of LDL cholesterol and insulin use were associated with poor blood glucose control. CONCLUSION. A small part of the sample simultaneously achieved the goals for blood glucose, lipids and blood pressure control. Some factors, such as age and gender can be determinants to achieve control of diabetes. Greater efforts are still needed to achieve the goals for treatment in type 2 diabetic patients.
引用
收藏
页码:314 / 321
页数:8
相关论文
共 50 条
  • [21] Baseline factors associated with the glycaemic response to treatment with once weekly dulaglutide in patients with type 2 diabetes
    Wysham, C.
    Guerci, B.
    D'Alessio, D.
    Jia, N.
    Botros, F. T.
    DIABETOLOGIA, 2015, 58 : S375 - S376
  • [22] Sitagliptin Monotherapy improved glycaemic control in patients with type 2 diabetes
    Aschner, P.
    Kipnes, M.
    Lunceford, J.
    Sanchez, M.
    Mickel, C.
    Davies, M. J.
    Williams-Herman, D.
    DIABETOLOGIA, 2006, 49 : 5 - 5
  • [23] Lixisenatide in patients with type 2 diabetes and obesity: Beyond glycaemic control
    Mar Roca-Rodriguez, M.
    Muros de Fuentes, Maria Teresa
    Piedrola-Maroto, Gonzalo
    Quesada-Charneco, Miguel
    Maraver-Selfa, Silvia
    Tinahones, Francisco J.
    Mancha-Doblas, Isabel
    ATENCION PRIMARIA, 2017, 49 (05): : 294 - 299
  • [24] Dimethylarginines in patients with type 2 diabetes mellitus: Relation with the glycaemic control
    Can, Ayten
    Bekpinar, Seldag
    Gurdol, Figen
    Tutuncu, Yildiz
    Unlucerci, Yesim
    Dinccag, Nevin
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 94 (03) : E61 - E64
  • [25] Do comorbidities impact on glycaemic control in patients with Type 2 diabetes?
    Hilvers, E.
    Kumarendran, B.
    Weber, P.
    Ryan, R.
    Ghosh, S.
    Bordbar, B.
    Marshall, T.
    Nirantharakumar, K.
    DIABETIC MEDICINE, 2016, 33 : 194 - 194
  • [26] Glycaemic control in Type 2 diabetes - not for sidelining
    Narendran, P.
    DIABETIC MEDICINE, 2008, 25 (06) : 639 - 642
  • [27] Glycaemic control in native Kuwaiti Arab patients with type 2 diabetes
    Channanath, Arshad M.
    AlWotayan, Rihab
    Alkandari, Hessa
    Davidsson, Lena
    Tuomilehto, Jaakko
    Thanaraj, Thangavel Alphonse
    PRIMARY CARE DIABETES, 2018, 12 (06) : 526 - 532
  • [28] Muscle Strength and Glycaemic Control among Patients with Type 2 Diabetes
    Bawadi, Hiba
    Alkhatib, Dana
    Abu-Hijleh, Haya
    Alalwani, Joud
    Majed, Lina
    Shi, Zumin
    NUTRIENTS, 2020, 12 (03)
  • [29] What is the best approach to glycaemic control in patients with type 2 diabetes?
    Garber, A. J.
    DIABETES OBESITY & METABOLISM, 2015, 17 (02): : 105 - 106
  • [30] Treatment intensification for patients with type 2 diabetes and poor glycaemic control
    Fu, A. Z.
    Sheehan, J. J.
    DIABETES OBESITY & METABOLISM, 2016, 18 (09): : 892 - 898